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CCR7 Governs Skin Dendritic Cell Migration
under Inflammatory and Steady-State Conditions
naive T cells as well as other DC through the interaction
with CCR7 (Luther et al., 2000; Sallusto et al., 1998). In
contrast to the widely accepted model for lymphocyte
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ficking are still largely unknown.1Institute of Immunology
Based on the chemokine receptor expression profileHannover Medical School
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found to be expressed in the inflamed skin, it has beenGermany
proposed that the production of chemokines at sites of2 Max-Delbruck-Center for Molecular Medicine
inflammation recruits bone marrow-derived immature13092 Berlin
DC to these places (Saeki et al., 1999; Sallusto et al.,Germany
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CCR4 ligands CCL22 and CCL17 (Campbell et al., 1999;
Katou et al., 2001); CCL20, the ligand of CCR6 (Dieu-
Nosjean et al., 2000); CCL2, which is a ligand of CCR2Summary
(Barker et al., 1991); as well as the CXCR3 ligands
CXCL9, CXCL10, and CXCL11 (Flier et al., 2001). Inter-The CC chemokine receptor CCR7 has been identified
estingly, most of the chemokine receptors mentionedas a key regulator of homeostatic B and T cell traffick-
were found on immature in vitro differentiated DC, whileing to secondary lymphoid organs. Data presented
mature DC have been shown to express primarily thehere demonstrate that CCR7 is also an essential medi-
chemokine receptors CCR7 and CXCR4, both known toator for entry of both dermal and epidermal dendritic
regulate homeostatic trafficking of lymphocytes (Dieucells (DC) into the lymphatic vessels within the dermis
et al., 1998; Sallusto et al., 1998). Thus, it has beenwhile this receptor is dispensable for the mobilization
postulated that a switch in chemokine receptor expres-of Langerhans cells from the epidermis to the dermis.
sion enables activated DC to leave the site of inflamma-Moreover, a distinct population of CD11cMHCIIhigh DC
tion and to migrate to the T cell zones of the draining LNshowing low expression of the costimulatory mole-
via afferent lymphatics. Indeed, we have demonstratedcules CD40, CD80, and CD86 in wild-type animals was
earlier that CCR7 deficiency, in addition to defective Tvirtually absent in skin-draining lymph nodes of CCR7-
and B cell homing, causes severely impaired migrationdeficient mice under steady-state conditions. We pro-
of activated Langerhans cells (LC) into draining LN (For-vide evidence that these cells represent a semimature
ster et al., 1999). Since impaired migration of LC haspopulation of DC that is capable of initiating T cell
also been observed in antigenically challenged plt/pltproliferation under conditions known to induce toler-
mice, which lack expression of the CCR7 ligands CCL19ance. Thus, our data identify CCR7 as a key regulator
and CCL21-Ser (Gunn et al., 1999), we were interestedthat governs trafficking of skin DC under both inflam-
in further clarifying the role of this chemokine receptormatory and steady-state conditions.
in DC migration.
We now provide strong evidence that, while CCR7
Introduction
seems to be dispensable for the initial mobilization of LC
within the epidermis, it is indispensable for DC migration
Chemokines are small chemotactic cytokines that regu- into afferent dermal lymphatics. Moreover, the absence
late the homeostatic migration of leukocytes through of the semimature DC population (CD11cMHCIIhigh,
lymphoid organs as well as the inflammation-induced CD40int, CD80low, CD86low) in LN of unchallenged CCR7-
recruitment of immune cells to sites of infection and deficient mice demonstrates that CCR7 is essentially
inflammation (Baggiolini, 1998; Cyster, 1999). Data ob- required for the steady-state migration of skin-derived
tained from gene-targeted mice revealed that the com- DC in the absence of inflammatory signals. We show
plex interactions between DC, T cells, and B cells within that these cells induce antigen-specific T cell activation
specialized compartments of lymphoid tissues are under conditions known to induce tolerance. Since
guided by a network of chemokines and chemokine adoptive transfers demonstrate that this function is se-
receptors (Cavanagh and Von Andrian, 2002). While na- verely impaired in CCR7-deficient animals, our data
ive T and B cells enter lymphoid organs following the point to a role of CCR7 in the maintenance of periph-
interaction of CCR7 with its ligands CCL19 and CCL21, eral tolerance.
which are expressed at the luminal site of high endothe-
lial venules, antigen-bearing DC migrate from the periph- Results
ery into lymphoid organs via afferent lymphatics (Forster
et al., 1999; Steinman, 1991). Once within the lymphoid CCR7 Is Required for the Entry of DC
organs, DC express CCL19, which is known to attract into Dermal Lymphatics
In an earlier study, we reported that CCR7-deficient mice
show a severe decrease in the accumulation of cutane-*Correspondence: foerster.reinhold@mh-hannover.de
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ous DC in skin-draining LN following skin painting with
FITC (Forster et al., 1999). However, it remained unclear
at which step CCR7 deficiency interferes with DC migra-
tion from the skin to the draining LN. Therefore, we
studied the migration process of these cells in greater
detail. Using a mAb specific for Langerin, there was no
obvious difference regarding shape and distribution of
Langerhans cells (LC) within freshly isolated epidermis
between wild-type and CCR7-deficient mice (Figures 1A
and 1B). In order to test the mobilization capacity of
peripheral DC in vitro, skin explants were floated on
culture medium. After 24 hr, the epidermis was sepa-
rated from the dermis and analyzed by immunohistol-
ogy. Within this period of time, LC changed their mor-
phologic appearance and decreased in numbers in both
wild-type and CCR7-deficient skin (Figures 1C and 1D).
At the same time, DC in the dermis of wild-type mice
gave rise to formations known as “dermal cords” (Figure
1E) representing the accumulation of MHCII DC includ-
ing Langerin-positive cells along dermal lymphatics after
the in vitro culture of skin explants (Larsen et al., 1990;
Weinlich et al., 1998). Interestingly, formations resem-
bling dermal cords were never observed in the dermis
of CCR7-deficient mice, although MHCII DC and Lang-
erin cells were present (Figure 1F). In contrast, analysis
of the culture medium collected 24 and 48 hr after the
onset of skin explant culture revealed a 3- to 4-fold
increase in the number of MHCIICD86 cells emigrated
into the culture medium of skin explants isolated from
CCR7-deficient mice when compared to wild-type mice
(Figure 1G). These data demonstrate that CCR7 is es-
sentially involved in the migration of DC towards or into
lymphatics within the dermis, an observation that is in
agreement with the expression of the CCR7-ligand
CCL21 in lymphatic endothelium (Saeki et al., 1999).
In Vivo Activation of Langerhans Cells
Analyzing the number and distribution of resident epi-
dermal DC in untreated wild-type and CCR7/ mice
using anti-langerin mAb staining on epidermal sheets
isolated from the ear, we could not observe any signifi-
cant difference with regard to distribution or density
Figure 1. Effects of CCR7 Deficiency on Distribution and Mobiliza-
of MHC class II cells between wild-type and CCR7 tion of Langerhans Cells and Skin Dendritic Cells
mutants. Wild-type epidermis harbored 454  35 MHC (A–F) To analyze LC distribution in the untreated skin, epidermal
class II cells/mm2 while that of CCR7-deficient animals sheets were prepared from the ear of wild-type (A) or CCR7/ (B)
contained 447  33/mm2 (mean  SD, p  0.01, Figure mice and stained with rat anti-Langerin mAb (clone 929F3) and
mouse anti-rat-Cy3. In the explant model, skin flaps were isolated1H, open columns). To further investigate the emigration
from wild-type (C and E) and CCR7/ (D and F) ear and floated onof LC from the epidermis, we applied an in vivo migration
tissue culture medium for 48 hr before epidermis (C and D) wasmodel. LC migration was induced by sensitizing the ear
separated from dermis (E and F) followed by staining with a rat anti-
skin with FITC, and 18 hr later the frequency of Langerin Langerin (C–F) or FITC-conjugated anti-MHCII mAb (E and F).
cells in the epidermis was analyzed. As shown in Figure (G) The number of CD86MHCII cells emigrated into the tissue
culture medium 24 hr and 48 hr after the onset of culture.1H, LC were mobilized from the epidermis of wild-type
(H) Ears of C57BL6 and CCR7/ mice were treated with 0.1% FITCand CCR7-deficient mice to the same extent. These
in acetone/dibutylphtalat or carrier alone. Mice were sacrificed 18data, together with the unimpaired in vitro emigration
hr later and epidermal sheets were stained with rat anti-Langerin
of CCR7-deficient LC from the epidermis (see Figures mAb (clone 929F3) and mouse anti-rat-Cy3, and the number of Lang-
1D and 1G), demonstrate that CCR7 is not required for erin-positive cells was determined by epi-fluorescent microscopy.
Data are derived from three images per epidermal sheet (10 origi-the initial step of LC mobilization, i.e., the migration from
nal magnification, 0.8 mm2/image) of at least six ears of each geno-the epidermis toward the dermis. Instead, our observa-
type and treatment (**p  0.01, unpaired t test).tions point to a decisive role for CCR7 in the entry of
activated LC into draining lymphatics once these cells
reach the dermis.
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Figure 3. Reduced Numbers of Distinct DC Subsets in CCR7-Defi-
cient Mice
The total number of different DC subtypes from wild-type (filled
columns) and CCR7-deficient (open columns) mice was determined
per LN by flow cytometry using the markers as indicated (pools of
10 skin-draining LN per animal; data from three C57BL6 and three
CCR7-deficient C57BL6 mice).Figure 2. CCR7-Deficient DC Fail to Migrate to Skin-Draining
Lymph Nodes
(A) In vitro differentiated, bone marrow-derived DC from wild-type
(Figure 3), there was no significant difference in numbersand CCR7-deficient mice were labeled with CFSE and TAMRA, re-
regarding CD4CD8 DC. In contrast, CD4 DC andspectively, mixed at equal numbers, and injected i.c. into the right
CD8 DC were reduced to 42% and 34%, respectively.foot pad. After 36 hr, the popliteal LN was removed and analyzed
for the presence of immigrated DC. Of interest, DC expressing both CD4 as well as CD8
(B) Same as (A) with the exception that wild-type DC were labeled were particularly scarce in the LN of CCR7/ mice (only
with TAMRA and CCR7-deficient DC with CFSE and cells were in- 17% of the cell count of wild-type mice; Figure 3). These
jected into the left food pad of the same mice used in (A).
data indicate that CCR7 deficiency causes an imbalance(C) Mean  SEM of the data derived from 8 popliteal LN of the
among defined subpopulations of DC present in periph-experiments shown in (A) and (B).
eral LN in the steady state. Further analysis revealed a
population of CD11cMHCIIhigh DC present in all skin-
draining but not organ-draining LN of wild-type mice
In Vitro Differentiated CCR7-Deficient DC Fail
that was almost completely absent in skin-draining LN
to Migrate into the Draining LN
of CCR7 mutants (Figures 4A–4C). Since we noticed
To further substantiate the hypothesis that CCR7 is re-
impaired migration of skin DC after skin sensitization in
quired for the entry of DC into lymphatics, we used bone
CCR7-deficient mice (data not shown and Forster et al.,
marrow-derived in vitro differentiated DC. TNF/PGE2- 1999), and based on the observation that 24 hr after
matured DC from wild-type and CCR7-deficient mice FITC-skin sensitization all FITC cells in the draining LN
were labeled with the fluorescent dyes CSFE (green) of wild-type mice display this particular CD11cMHCIIhigh
and TAMRA (red), respectively, mixed at equal numbers phenotype (data not shown), we further characterized
and injected i.c. into the right footpad of wild-type mice. this cell population. In wild-type animals within the pop-
In order to rule out that the dye-labeling procedure ad- ulation of CD11cMHCIIhigh, a subpopulation exclusively
versely influences the migration of the DC, TAMRA- expressed CD207/Langerin, a marker thought to be spe-
labeled wild-type and CSFE-labeled CCR7/ DC were cific for LC (Figure 4D). These data indicate that these
injected into the left footpad of the same animals. As skin-derived LC show a CD11cMHCIIhigh phenotype
demonstrated in Figures 2A and 2B, only DC derived once they reached the draining LN. Neither the very few
from wild-type mice could be identified in significant remaining cells in the gate containing CD11cMHCIIhigh
numbers in the popliteal LN 36 hr after transfer, while cells nor CD11c cells with lower expression levels of
the CCR7-deficient DC failed to immigrate into the LN MHCII in the skin-draining LN of CCR7/ mice ex-
(Figure 2C). These data are consistent with previous pressed CD207 (Figure 4E), indicating that CCR7 is in-
findings (Martin-Fontecha et al., 2003) and further sup- dispensable for the steady-state migration of LC to
port the hypothesis that CCR7 is essentially required lymphoid organs.
for DC to migrate from the skin toward the LN via the In order to further substantiate the hypothesis that
CCL21 expressing lymphatics. CD11cMHCIIhigh cells represent DCs that migrate to LN
under steady-state conditions, Balb/c mice that were
born and maintained in a germ-free environment were
Lack of CD11cMHCIIhigh Cells under Steady-State analyzed. In skin-draining LN of these animals, CD11c
Conditions in Skin-Draining LN MHCIIhigh cells were identified in numbers comparable
of CCR7-Deficient Mice to those obtained from SPF animals (data not shown).
Since several distinct DC populations have been identi- It has recently been suggested that epidermal DCs are
fied in lymphoid organs in the mouse, presumably serv- CD40highCD11chigh while dermal DCs are CD40highCD11cinter
ing different biological functions (Shortman and Liu, in LN (Ruedl et al., 2000). Expression of these markers
2002), we further analyzed the subpopulations of DC was assessed on DCs isolated from wild-type and
present in peripheral LN. While the total number of CCR7-deficient LN. We observed that CD40highCD11chigh
LC are virtually absent in CCR7-deficient mice (popula-CD11cDC was reduced to 60% in CCR7-deficient mice
Immunity
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Figure 5. Expression of CCR7 on LN Dendritic Cells and Freshly
Isolated Epidermal Dendritic Cells
Lymph node cells (upper panel) or cells isolated from ear epidermis
(lower panel) of C57BL6 mice were stained with anti-MHCII, anti-
CD11c, and rat anti-mCCR7 (solid line) or isotype control (shaded
area) and mouse anti-rat-Cy5. Expression of CCR7 on CD11c cells
expressing intermediate levels of MHCII (left column) and high levels
Figure 4. Lack of Skin-Derived DC and Langerhans Cells in Skin- of MHCII (right column) is shown.
Draining LN of CCR7-Deficient Mice
(A and B) LN cells derived from 10 skin-draining LN (inguinal, axillary,
brachial, popliteal, and facial) of C57BL6 (A) and CCR7-deficient
is differently expressed on DC. Applying a recently gen-C57BL6 (B) mice were pooled and analyzed for the expression of
erated anti-CCR7 mAb, the CD11cMHCIIhigh population,CD11c and MHCII.
which is missing in CCR7-deficient mice, was found to(C) Number of cells falling within the upper right gate shown in (A)
and (B) (data derived from three wild-type and three mutant mice of uniformly express CCR7, while this chemokine receptor
one experiment; similar data were derived from at least six additional was only expressed on a subpopulation of CD11c
mice of each genotype). MHCIIinter DC (Figure 5, upper panel). The expression of
(D) Langerin cells were found only in the CD11cMHCIIhigh DC popu-
CCR7 on LC residing in the epidermis was then investi-lation (solid line, upper right gate shown in [A] and [B]) present in
gated. Analyzing freshly isolated epidermal LC, it waswild-type mice, whereas MHCIIinter DC (dotted line, middle right gate
possible to separate these cells based on the amountshown in [A] and [B]) do not express Langerin.
(E) In CCR7-deficient mice, neither the residual MHCIIhigh nor the of surface MHCII molecules into two groups: MHCIIinter
MHCIIinter DC population contained any Langerin cells. and MHChigh (data not shown). However, no CCR7 ex-
(F and G) Skin-draining lymph nodes of CCR7-deficient mice lack pression was found on MHCIIinter LC, while CCR7 expres-
CD40high DC populations containing skin-derived DC. Cells from skin-
sion was evident on MHCIIhigh LC to some degree (Figuredraining LN of four wild-type mice (F) and four CCR7/ mice were
5, lower panel). These data indicate that some DC in theenriched for DC by density gradient centrifugation. DC were stained
skin start to spontaneously upregulate CCR7, therebywith anti-CD11c and anti-CD40.
allowing steady-state trafficking to the draining LN.
tion III in Figures 4F and 4G). CD40highCD11cinter cells,
CD11cMHCIIhigh Cells Are Semimature
which contain dermal DC, are also strongly reduced in
DC at Steady State
CCR7/ mice (population II in Figures 4F and 4G). A
It has been reported that skin DC migrating under nonin-
third DC population characterized as CD40interCD11chigh
flammatory conditions into the draining LN display a
(population I in Figures 4F and 4G), which has not been
semimature phenotype, since they express high levels
associated with skin DC (Ruedl et al., 2000), is present
of MHCII molecules typical for matured DC, but lack
in CCR7-deficient mice. These data add further evidence
high expression levels of costimulatory molecules such
to our hypothesis that CCR7 controls the migration of
as CD80 and CD86 (Lutz and Schuler, 2002; Stoitzner
both epidermal and dermal DCs under steady-state con-
et al., 2003). Therefore, we further characterized CD11c
ditions.
MHCIIhigh cells from skin-draining LN for the expression
of costimulatory molecules with and without prior FITC
skin painting. The epicutaneous application of FITC in-Expression of CCR7 on Lymph Node
and Epidermal DC duced a strong mobilization of CD11cMHCIIhigh cells,
increasing the proportion of this particular cell popula-Since CCR7-deficient mice missed several DC popula-
tions in peripheral LN, it was of interest whether CCR7 tion within all LN cells from 3.4% to 8.6% (mean of 6
CCR7 in DC Migration
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Impaired Proliferative Response of Antigen-Specific
T Cells after Dermal Antigen Application
in CCR7/ Mice
To further clarify whether the impaired migration of acti-
vated skin DC observed in the FITC painting model has
implications for the subsequent stimulation of adop-
tively transferred antigen-specific T cells, the OT-II
adoptive transfer system was applied to C57BL6 and
CCR7/ C57BL6 mice. OT-II T cells express an oval-
bumin-specific MHCII-restricted T cell receptor and can
be used as a model for antigen-specific T cell responses.
Intracutaneous/subcutaneous (i.c./s.c.) application of
various amounts of antigen (0.1 g to 10 g) together
with CpG-DNA as an adjuvant induced a strong and
dose-dependent induction of antigen-specific T cell pro-
liferation in wild-type mice (Figure 7A, upper panel). This
proliferative response was markedly reduced when
OT-II cells (CCR7-positive) were transferred to CCR7-
deficient mice. Under these experimental conditions—
CCR7 deficiency affects DC but not T cell migration—a
moderate proliferative response was identified at the
highest amount of antigen applied (10g), while prolifer-
ation was barely detectable at lower doses (Figure 7A,
lower panel).
We next tested the potential of i.c./s.c. applied LPS-
free antigen to promote antigen-specific proliferation of
T cells in the draining LN in the absence of adjuvant
and danger signals. In accordance with previous results,
proliferation of adoptively transferred MHCII-restricted
OT-II cells was strongly induced in the draining LN of
wild-type mice after i.c./s.c. application of small amounts
of soluble antigen (Figure 7C), while no proliferating anti-
gen-specific T cells were identified after PBS injection
to the contralateral side (Figure 7D). As described aboveFigure 6. Steady-State CD11cMHCIIhigh DC in Wild-Type Mice Dis-
for inflammatory conditions, a dose-dependent prolifer-play a “Semimature” Phenotype
ation of OT-II cells was observed only if cells were trans-Cells from skin-draining LN of naive wild-type mice (A) or of mice
ferred into wild-type animals (Figure 7C, upper panel)24 hr after FITC skin painting (B) were analyzed for expression of
MHCII and CD11c. The numbers shown represent the percentage but not after transfer into CCR7-deficient recipients (Fig-
of cells within the CD11cMHCIIhigh population derived from six ure 7C, lower panel). In the latter case, no proliferation
draining LN each. (B) The CD11cMHCIIhigh subpopulation was fur- was observed at 0.1 g and 1 g OVA while a very weak
ther analyzed for expression of costimulatory molecules CD40 (C), response was found at 10 g OVA.
CD80 (D), and CD86 (E) as well as for Langerin (F). Shaded area,
Conjugation of antigen to the anti-CD205 mAbisotype control; dotted line, gate on CD11cMHCIIhigh cells of un-
NLDC145 has been shown to allow efficient presentationtreated mice; solid line, gate on CD11cMHCIIhigh FITC cells 18 hr
of the conjugated antigen in MHCII molecules and alsoafter FITC skin painting.
permits effective crosspresentation in MHCI molecules
(Bonifaz et al., 2002; Hawiger et al., 2001). Application
LN, Figures 6A and 6B). After sensitization with FITC, a of this antigen:mAb conjugate allows antigen targeting
moderate increase in CD40 expression accompanied by to DC without maturation, thus resembling DC migration
a profound upregulation of CD80 and CD86 was ob- and antigen presentation in the steady state. Again, fol-
served in the FITC CD11cMHCIIhigh cell population, lowing the application of OVA coupled to anti-CD205,
when compared with the cells in LN of untreated mice no substantial proliferation of OT-II cells occurred in
(Figures 6C–6E). The percentage of CD207 DC within the draining LN of CCR7-deficient mice. Draining LN
the CD11cMHCIIhigh population was not increased by contained only approximately 4 times the number of
FITC painting, suggesting that, in addition to LC, other proliferating T cells compared to those observed in the
skin-derived DC essentially contribute to the population nondraining LN, while this number was increased 165-
of FITC-positive DC isolated from draining LN (Figure fold when comparing draining and nondraining LN in
6F). The phenotype of the CD11cMHCIIhigh cells—low wild-type animals (Figure 7E, data not shown). In order
levels of costimulatory molecules that are upregulated to rule out that priming did occur in CCR7-deficient
following activation—indicate that these cells are possi- mice but was not sufficient to induce proliferation, the
bly semimature, steady-state migratory DC. Since the expression of the early activation marker CD69 was ana-
migration of these cells is strongly impaired in CCR7- lyzed 36 hr after immunization with 1 g OVA without
deficient mice, our data point to a pivotal role for CCR7 adjuvant. As shown in Figure 7F, a profound upregula-
in the migration of skin DC to the skin-draining LN under tion of CD69 on OT-II cells was observed upon adoptive
transfer into wild-type recipients but not when trans-inflammatory as well as under steady-state conditions.
Immunity
284
intravenously into wild-type and CCR7-deficient mice.
A comparable proliferative response of the OT-II cells
was observed irrespective of transfer to wild-type or
CCR7-deficient recipients (Figure 7G).
Discussion
Several lines of evidence suggest that DC reprogram
their chemokine receptor expression profile during
defined maturation stages. One of the two chemokine
receptors expressed on mature but not on immature
bone marrow-derived DC is CCR7 (Sallusto et al., 1998;
Yanagihara et al., 1998), a receptor also known to regu-
late entry of lymphocytes into LN (Forster et al., 1999)
and the antigen-induced migration of B cells from the
B cell follicle to the outer T cell area during the initiation
of a B cell immune response (Reif et al., 2002). In addi-
tion, it has been shown previously that the migration of
skin DC toward the draining LN is impaired in CCR7-
deficient mice under inflammatory conditions (Forster
et al., 1999).
Within the heterogeneous group of DC, LC represent
the population of skin-resident DC that have been most
intensely studied with regard to their migratory proper-
ties. LC reside within basal and suprabasal laminae of
the epidermis and are equipped with the machinery to
capture and process potentially harmful pathogens at
the time that they invade the body, thereby rapidly initiat-
ing an immune response (Schuler and Steinman, 1985;
Stingl et al., 1980). It has been known for a long time
that skin DC, including LC, are mobilized to migrate to
the draining LN once they have been activated, but re-
cent work demonstrated that these cells are also found
in the draining LN in the absence of an inflammatory
event, suggesting a continuous turnover of DC, a pro-
Figure 7. CCR7-Deficient Mice Show Impaired T Cell Response in cess described as steady-state migration (Hemmi et al.,a Model of T Cell Triggering by s.c. Applied Antigen under Inflamma-
2001; Merad et al., 2002; Yoshino et al., 2003).tory and Steady-State Conditions
Data presented here strongly suggest that CCR7 is(A–D) 24 hr after adoptive transfer of CFSE-labeled OT-II cells into
involved in both activation-induced as well as steady-C57BL6 and CCR7/ mice, OVA (0.1–10 g as indicated) was in-
state turnover of skin DC. FITC-bearing CD11cMHCIIhighjected s.c. into recipient’s left ear (A and C) while PBS was injected
into the same recipient’s right ear (B and D) together with 10 g cells are absent in the draining LN after skin sensitization
CpG1668 (A and B) or without adjuvant (C and D). Proliferation of of CCR7-deficient mice (inflammatory condition). More
the OT-II cells in the draining LN was analyzed 72 hr after antigen importantly, CD11cMHCIIhigh cells are also missing in
application. Data shown for each experimental setup are represen-
the skin-draining LN under steady-state conditions. Thistative for at least six LN. For PBS injection, data are shown for right
phenotype is corroborated by the observation that afacial LN of mice that received 10 g OVA into their left ear.
considerable proportion of CD11cMHCIIhigh cells ex-(E) Instead of soluble OVA, ovalbumin chemically coupled to
NLDC145 mAb (1 g) was used for s.c. application in the same press CCR7 at a moderate level already in the epidermis,
adoptive transfer model. indicating their imminent emigration. In skin-draining LN
(F) OT-II cells, adoptively transferred to C57BL6 wild-type mice, of wild-type mice, either after skin sensitization or in the
strongly upregulate the activation marker CD69 36 hr after s.c. appli-
steady state, a subpopulation of these CD11cMHCIIhighcation of 1 g LPS-free OVA, while OT-II cells transferred to CCR7-
cells expresses the Langerhans cell marker Langerin,deficient mice show weak upregulation on few TCR transgenic cells;
CD207 (see Figure 4), suggesting that CCR7 is involvedshaded area, isotype control.
(G) Intravenous application of 1 mg OVA induces comparable prolif- in recruiting LC as well as other skin-derived DC into
eration of adoptively transferred OT-II cells in peripheral LN of wild- skin-draining LN under inflammatory and steady-state
type and CCR7-deficient mice. conditions.
Although less pronounced than observed in CCR7/
mice, impaired mobilization of activated skin DC hasferred to CCR7-deficient mice. These data suggest that
transport of antigen to the draining lymph node is im- also been reported in a naturally occurring mutant, the
paucity of lymph node T cells (plt/plt) mouse (Gunn etpaired due to lack of CCR7 on APC, thereby hampering
T cell activation. However, if lack of antigen bearing APC al., 1999). This strain carries a deletion leading to loss
of CCL19 expression as well as expression of one ofis a limiting event in the LN of CCR7-deficent mice,
systemic application of antigen should overcome this the two CCL21 genes. The CCL21 gene missing in plt/
plt mice codes for a CCL21-ser gene product that differsrestriction. To test this idea, 1 mg OVA was injected
CCR7 in DC Migration
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in a single position from a second, CCL21-leu gene that the initial mobilization of LC within the epidermis, since
no differences regarding the emigration of LC from theis still present in plt/plt mice. While the CCL21-ser
gene is specifically expressed in lymphoid organs, epidermis were observed between wild-type and CCR7-
deficient mice following activation with FITC (Figure 1H).CCL21-leu is in particular found in nonlymphoid organs
including lymphatic vessels of the skin (Luther et al., The impaired migration of cutaneous DC observed in
CCR7-deficient mice is reflected by the reduced capac-2000; Nakano and Gunn, 2001; Vassileva et al., 1999).
This residual expression of CCL21-leu in plt/plt mice ity of CCR7-deficient mice to induce antigen-specific
T cell proliferation after s.c. or i.d. application of antigen.might explain why activated skin DC are still able to
form “dermal cords” in a skin explant model and to Small amounts of antigen without additional adjuvant,
reflecting tolerance-inducing conditions, failed to in-migrate to draining LN in plt/plt mice (Gunn et al., 1999)
but not in CCR7/ mice. Residual expression of CCL21 duce proliferation of antigen-specific lymphocytes in the
draining LN of CCR7-deficient hosts. However, thisin plt/plt mice might also be responsible for unaffected
steady-state migration that has been recently reported small dose of antigen is capable of inducing a vigorous
proliferation of the adoptively transferred OT-II T cellsin these mice (Yoshino et al., 2003).
There is now accumulating evidence for a consider- in wild-type hosts (Figure 7). The correlation of impaired
DC migration and lack of antigen-specific proliferationable proportion of DC of LN and spleen constitutively
presenting self-antigens in the steady state, a mecha- in CCR7-deficient mice suggests that efficient T cell
stimulation after low-dose antigen application can onlynism believed to induce tolerance (Hugues et al., 2002;
Wilson et al., 2003). Application of endotoxin-free anti- be triggered by specialized antigen-presenting cells,
most likely by CD11cMHCIIhigh DC entering the draininggens without adjuvant, or antigens specifically coupled
to an anti-CD205 mAb, mimics confrontation of an or- LN. In contrast, a higher dose of antigen together with
adjuvant was sufficient to induce a weak proliferation ofganism with a harmless or self-antigen, and recent stud-
ies demonstrated that DCs presenting antigen under antigen-specific T cells in CCR7-deficient hosts. Passive
transport of soluble antigen with the lymph fluid or bysuch conditions, i.e., DCs under steady state, will not
induce an inflammatory immune response. Although cells other than the described CD11cMHCIIhigh cells
might contribute to presentation to and stimulation ofthey are able to vigorously stimulate T cell proliferation,
these proliferated T cells are unresponsive to further T cells in the LN, although at lower efficiency. The idea
that impaired migration of DC from the skin to the drain-stimulation and are eliminated a few days later, most
likely due to lack of costimulatory signals (Bonifaz et ing LN represents the limiting factor for the delivery of
antigen to the LN of CCR7-deficient mice is supportedal., 2002; Hawiger et al., 2001). The characteristics of
these tolerance-inducing cells, which have also been by our finding that intravenous application of antigen
induced a profound proliferative response of OT-II cellscalled “semimature DC,” have been reviewed recently
(Lutz and Schuler, 2002). Stoizner et al. (2003) character- in both wild-type and CCR7-deficient animals. Neverthe-
less, since LN are morphologically altered in CCR7-defi-ized steady-state migration of LC. Using a mAb specific
for Langerin, they demonstrate that in steady state, LC cient mice, we cannot entirely exclude the possibility
that disturbed LN architecture might partially contributepresent in skin-draining LN express low levels of matura-
tion markers such as 2A1, CD86, and CD40 and high to the reduced proliferative response of adoptively
transferred T cells following antigen application.levels of MHCII as well as CD11c. These observations
are in accordance with the data presented here. Lang- The present study also reveals that in addition to re-
cently immigrated skin DC, other subsets of DC are alsoerin cells are identified as part of the CD11cMHCIIhigh
population, which is entirely missing in CCR7-deficient diminished in LN of CCR7 mutants. The function and
kinetics of the different DC subpopulations identified inmice under steady-state conditions. Peripheral LN of
germ-free mice invariantly possess this DC population, lymphoid organs of man and mouse are currently under
intense investigation. In mouse LN and spleen, variousexcluding the possibility that our observation of a contin-
uously mobilized DC population was caused by ongoing DC subsets expressing different surface markers were
recently identified (reviewed in Shortman and Liu, 2002).but clinically not apparent infectious processes in the skin.
Our data derived from skin explant cultures confirm One of these subsets, classified by its expression of
CD8 (formerly designated as the lymphoid DC subset),the hypothesis that CCR7 is selectively required to allow
skin DC with a mature or semimature phenotype to enter is in particular missing in CCR7-deficient mice. Since it
has been suggested that CD8 DC are involved in theskin lymphatics. In vitro cultures of skin explants induce
the accumulation of DC along dermal lymphatics in wild- induction of TH1 responses (Maldonado-Lopez et al.,
1999; Pulendran et al., 1999) as well as in the inductiontype mice, the so called “dermal cords,” an artificial
structure occurring in experimental situations when the of tolerance (Belz et al., 2002) to peripheral self-antigen,
it will be worth studying these mechanisms in mice car-flow of lymph fluid is abrogated (Larsen et al., 1990). The
formation of dermal cords is also observed in explant rying a DC-specific deletion of CCR7.
Our data provide ample evidence that CCR7 is essen-culture of skin derived from plt/plt mice, which express
CCL21-Leu in dermal lymphatics (Gunn et al., 1999). tially required for skin DC and LC migration into dermal
lymphatics under inflammatory conditions, thus guidingIn contrast, cultured skin derived from CCR7-deficient
mice is completely devoid of these structures, pointing them on their way to the draining LN. A CCR7-based
mechanism is also effective in directing semimature skinto a critical role of CCR7 in the migration of skin DC
toward and into dermal lymphatics. The decisive and DC and a subpopulation of LC under steady-state condi-
tions to the skin-draining LN, cells that are thought toselective role for CCR7 in guiding cutaneous DC into
skin lymphatics was corroborated by in vivo mobilization play a pivotal role in the maintenance of peripheral toler-
ance. Since CCR7/ mice are not prone to spontane-experiments, indicating that CCR7 is not required for
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-mercaptoethanol; one volume of fresh medium was added at dayously develop autoimmune diseases, it seems likely that
3, and on day 6 one volume was replaced by fresh medium. GM-other mechanisms are able to compensate the impaired
CSF was produced by a NIH-3T3 cell line infected with Psi2-steady-state DC migration in the induction of peripheral
pM5DGM#6 (Qin et al., 1997). On days 7 to 9, the culture medium
tolerance. Alternatively it seems plausible that poten- was supplemented with 30 ng TNF/ml (R&D Systems) and 1 g/ml
tially autoreactive T cells present in CCR7-deficient prostaglandin-E2 (PGE2, Sigma) to induce maturation. Analysis of
cells obtained with this procedure revealed that 	90% expressedmice are not efficiently activated, since naive T cells are
CD11c with 50%–60% showing high levels of MHCII and in the casealso severely hampered from gaining entry into LN of
of wild-type donors these cells also expressed high levels of CCR7.CCR7/mice, leading to impaired T cell-DC interaction.
For labeling cells with fluorescent dyes, 107 cells/ml DC in HBSS/In summary, our data identify CCR7 as a conductor
2%FCS were incubated with either 3 M CFSE or 10 M TAMRA
within an orchestra of molecules directing the egress (Molecular Probes) for 10 min at 37
C. A mixture of each 106 CFSE-
of DC from the skin under inflammatory and steady- and TAMRA-labeled DC was injected in a volume of 30 l into the
foot pad of wild-type recipients.state conditions.
Experimental Procedures Flow Cytometry
To obtain single cell suspensions of LN and spleen, organs were
Mice minced through a nylon mesh and washed with PBS supplemented
CCR7/ mice (mixed Balb/c 129Sv/Ev genetic background) have with 3% FCS and 5 mM EDTA. Erythrocytes of the spleen were
been described earlier (Forster et al., 1999) and were used for the removed by hypotonic lysis with NH4Cl. Cells were stained withexperiments shown in Figure 1G. For all other experiments, CCR7- antibodies against MHCII, CD4, CD11c, CD40, CD80, CD86, V2,
deficient mice were used that had been backcrossed for seven and V5.1-5.2 (Becton Dickinson) and CD8, CD69 (Caltag, Ger-
generations to the C57BL/6 genetic background. Mice were main- many) as described earlier (Fo¨rster et al., 1994). CCR7 expression on
tained under SPF conditions and used at 8–12 weeks of age. All LN or epidermal DC was detected by staining with rat-anti-mCCR7
animals including germ-free Balb/c mice were maintained at the (clone 4B12) that will be described elsewhere (U. Ritter et al., submit-
central animal facility of Hannover Medical School. The MHCII- ted). The specificity of this antibody has been confirmed in the
restricted T cell receptor transgenic OT-II mice have been described present study by lack of staining on DC and T cells isolated from
earlier (Barnden et al., 1998). CCR7/ mice (data not shown). For the detection of Langerin
(CD207) expression, cells were fixed with 1% paraformaldehyde for
Preparation of Epidermal Sheets and Fluorescent 10 min on ice, washed, and resuspended in 0.1% saponin (Sigma,
In Situ Staining of Skin DC Germany) in PBS containing 3% FCS for 15 min at RT. Cells were
Epidermal sheets were obtained from ears of wild-type and CCR7/ stained with anti-Langerin (clone 929F3) or an isotype control
mice as described earlier (Price et al., 1997). Briefly, ears were split antibody. The anti-Langerin mAb was detected using mouse anti-
into dorsal and ventral halves and floated split side down for 2 hr rat-Cy5.
on 20 mM EDTA in PBS at 37
C. The epidermis was separated from
the dermis with fine forceps, washed twice in PBS, and fixed in ice-
Isolation of Langerhans Cells from the Epidermiscold acetone for 20 min at room temperature (RT). After rehydration
Epidermal sheets of untreated mice were prepared as describedin PBS, sheets were permeabilized in PBS containing 0.1% saponin
above and cut into small pieces, which were digested with 0.1 mg/(Sigma, Germany). After blocking with 5% mouse serum, sheets
ml collagenase D (Roche) in PBS containing 10% FCS for 30 minwere stained with rat anti-mouse Langerin mAb (clone 929F3, kindly
at 37
C. The digested epidermal pieces were minced and filteredprovided by Sam Saeland, Schering-Plough, France) followed by
through a nylon mesh and LC were stained with anti-MHCII-FITC,mouse anti-rat-Cy3 (Dianova, Germany). All staining and washing
anti-CD11c-biotin/streptavidin-PerCP, and anti-CCR7 or isotypesteps were performed in PBS supplemented with 0.1% saponin.
control.Sheets were mounted with 17.5% Moviol (Calbiochem) in 25% glyc-
erol and 100 mM Tris and images were made using an Axiovert
200M microscope and Axiovision 3.0 software (Carl Zeiss, Germany). Monitoring of Antigen-Specific T Cell Proliferation Responses
In Vivo
Skin Explant Culture and Staining of Emigrated Cells LN cells isolated from OT-II mice were labeled with CFSE as de-
As described elsewhere (Price et al., 1997), ears were split into scribed elsewhere (Lyons and Parish, 1994). In brief, 107 cells/ml
dorsal and ventral halves and floated split side down on 1 ml medium were incubated in RPMI supplemented with 10% FCS, 25 mM
containing RPMI, 10% FCS, and 50 M -mercaptoethanol for 24 HEPES (pH 7.4), and 5 M CFSE for 10 min. The frequency of V2/
or 48 hr. Emigrated nonadherent cells were counted, washed in V5.1-5.2 CD4 T cells was determined by flow cytometry. A total
PBS/2%FCS, blocked with Fc-block reagent (CD16/CD32, BD Bio- number 2  106 V2 V5.1-5.2 CD4 cells were transferred into
sciences) for 20 min at 4
C, and stained with anti-I-Ab-PE and anti- recipient mice by i.v. injection. After 24 hr, mice were immunized s.c./
CD86-FITC (BD Biosciences) to determine the number of emigrated i.d. in the ear and hind footpad with variable amounts of ovalbumin
DC from the skin. (0.1–10 g OVA, Grade VI, Sigma) and 10 g CpG1668 (TIB MolBiol,
Germany) and contralaterally with 10 g CpG alone. Mice were
In Vivo Activation of DC sacrificed 72 hr later. Antigen-specific V2 V5.1-5.2 CD4 cells
The emigration of epidermal DC was induced in vivo by applying of the OVA draining and contralateral nondraining LN were analyzed
50 l of 0.1% FITC in carrier solution (1:1 v/v aceton:dibutylphtha- for proliferation, which is indicated by the dilution of CFSE-fluores-
late) onto the right and left ear or by applying 100 l of the solution cence intensity.
onto the shaved abdomen. Control animals received the same To test the stimulatory capacity of skin DC under steady-state
amount of carrier solution without FITC. The animals were sacrificed conditions, experiments were performed according to those de-
18–24 hr later. For histological analysis, the ears were removed. scribed by Hawiger et al. (2001) and Bonifaz et al. (2002). OT-II cells
For quantification of LC in the epidermis, epidermal sheets were were CFSE labeled and adoptively transferred as described above.
prepared, stained, and analyzed as described above. Various amounts of LPS-free OVA (5 EU/mg, prepared by filtra-
tion on Detoxygel columns [Pierce] and tested with LAL QCL-1000
[BioWhittaker-Cambrex] according to the manufacturer’s instruc-In Vitro Differentiation and In Vivo Migration
of Bone Marrow DC tions) were injected s.c./i.d. into the ear and hind footpad. In another
set of experiments, ovalbumin was conjugated to an anti-CD205Bone marrow DC of wild-type and CCR7-deficient mice were gener-
ated based on a protocol developed by Lutz et al. (1999). In brief, mAb (clone NLDC145) as described previously (Bonifaz et al., 2002).
Following adoptive transfer of OT-II cells, mice received 1 g anti-2  106 bone marrow cells were cultivated for 7 days in RMPI
supplemented with 100 ng/ml GM-CSF, 10% FCS, and 50 M CD205:OVA conjugate in PBS s.c.
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